Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The ACR’s Advocates for Arthritis Volunteers Meet with Congress

Staff  |  Issue: September 2014  |  September 1, 2014

ACR advocates recently returned to Capitol Hill to meet with members of Congress as part of the Advocates for Arthritis fly-in conference on Sept. 8–9. This annual event brings together rheumatology professionals and patients to advocate on behalf of the rheumatology community. Here are the core issues on which advocates focused this year:

Patient Access to Treatments

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  • Co-sponsor H.R. 460, the Patients’ Access to Treatments Act. This legislation, which was spearheaded by the ACR and Arthritis Foundation, would limit cost sharing for specialty tier drugs—like biologics—to what plans require for nonpreferred brands. Thanks to the efforts of the rheumatology community and partnering groups, the bill has more than 135 bipartisan cosponsors.

Patient Access to Care

  • Repeal and replace the SGR with a system with multiple options that recognizes the specialized care rheumatologists provide; and
  • Support H.R. 1416 to exempt physician-administered drugs from Medicare sequestration and increase patients’ ability to access Part B treatments in their rheumatologist’s office.

Funding for Research

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • Support S. 2658, the Accelerating Biomedical Research Act, sponsored by Sen. Tom Harkin (D-Iowa). This legislation would create a budget cap adjustment for NIH funding over the remaining fiscal years of the Budget Control Act (BCA), allowing for increased funding for innovation and the discovery of new treatments and cures.

Join Your Colleagues in Advocacy this Month!

  • Your participation is important. Write, call or e-mail your members of Congress in September. As a constituent, your opinions matter to those who are elected to represent you. Speak up, and let them know how you feel about the important issues facing rheumatology. Make a note to visit the ACR legislative action center in September to send your message to Congress and add your voice to your colleagues’ efforts on Capitol Hill: www.rheumatology.org/actioncenter/; and
  • Schedule an in-district meeting with your members of Congress. Meeting face to face with your legislators and their staff provides you the opportunity to educate them on the issues and helps you to build and strengthen relationships. Contact ACR government affairs staff at [email protected] if you need assistance preparing for the meeting.

Be sure to involve your patients and staff; they’re constituents, too. Help spread the word by asking your patients and staff to share their experiences with members of Congress and to get involved in advocacy.

Share: 

Filed under:From the CollegeLegislation & AdvocacyProfessional TopicsResearch Rheum Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)ArthritisCongressdrugLegislationMedicarepatient careResearchrheumatology

Related Articles

    In Advocacy, Slow and Steady Wins the Race

    April 1, 2010

    Earlier in the year, it seemed that healthcare reform was stopped in its tracks because of the Massachusetts Senate special election—which placed Republican Scott Brown in the seat held by the “Liberal Lion,” Edward M. Kennedy. The Senate Democrats lost their supermajority and the momentum to pass President Obama’s healthcare reform legislation subsided. But through strong lobbying by the president, Speaker Nancy Pelosi (D-Calif.), and Senate Majority Leader Harry Reid (D-Nev.), Congress passed the Patient Protection and Affordable Care Act (H.R. 3590)—comprehensive healthcare reform—on March 21, and the president signed the bill into law on March 23.

    Why We Are Advocates

    September 5, 2012

    Rheumatology advocacy efforts are paying off in 2012.

    A Unified Advocacy Voice for Rheumatology

    June 13, 2021

    One thing that became clear very quickly this past year was that the COVID-19 pandemic would change the way we deliver care to patients. What has not changed amid an evolving healthcare landscape is our driving focus to ensure our patients’ access to rheumatology care and the availability of state-of-the-art treatments. We know you share…

    Update on Legislation, Advocacy Efforts to Advance Rheumatology

    September 1, 2014

    Status of progess to fix sustainable growth rate physician formula, other rheumatology-related issues facing Congress

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences